IFGL Refractories Appoints Mukesh Rawal as Whole-time Director & CEO (India)

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
IFGL Refractories Appoints Mukesh Rawal as Whole-time Director & CEO (India)

IFGL Refractories has appointed Mr. Mukesh Harshadrai Rawal as Whole-time Director and CEO (India) for a three-year term starting August 16, 2026. Rawal, with extensive experience since 1983 and former President of the US subsidiary, will now lead domestic operations.

IFGL Refractories Appoints Mukesh Rawal as CEO (India)

IFGL Refractories Limited has appointed Mr. Mukesh Harshadrai Rawal as its Whole-time Director and CEO for India operations. His tenure will be for three years, commencing August 16, 2026, and concluding on August 15, 2029. This appointment is pending necessary approvals, including from shareholders and the Central Government.

What just happened

Mr. Rawal, a US national of Indian origin with a Bachelor of Engineering in Metallurgy, has been associated with the IFGL Group since 1983.

Why this matters

This strategic move brings a seasoned executive with deep experience in refractories, iron, and steel industries to lead the company's domestic business.

The backstory

Previously, Mr. Rawal served as the President of the company’s US subsidiary, Mono Ceramics Inc., and headed its Americas operations. He will relinquish these international responsibilities by August 15, 2026.

What changes now

Rawal's transition from international leadership to spearheading the Indian operations aims to leverage his global expertise for the company's growth within India.

Risks to watch

The appointment is subject to shareholder and Central Government approvals, which investors should monitor.

Peer comparison

(No peer comparison data available in the filing.)

Context metrics (time-bound)

  • Appointment effective date: August 16, 2026
  • Appointment tenure: 3 years
  • Term expiry: August 15, 2029

What to track next

Investors should watch for the successful completion of all required regulatory and shareholder approvals.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.